Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | RXRA | P19793 | 7/20 | 0.33 |
| ▸ | GRIN1 | Q05586 | 7/20 | 0.33 |
| ▸ | GRIN2B | Q13224 | 7/20 | 0.33 |
| ▸ | PARP1 | P09874 | 1/20 | 0.33 |
| ▸ | ABCC9 | O60706 | 3/20 | 0.32 |
| ▸ | ABCC8 | Q09428 | 3/20 | 0.32 |
| ▸ | KCNJ11 | Q14654 | 3/20 | 0.32 |
| ▸ | KCNJ8 | Q15842 | 3/20 | 0.32 |
| ▸ | IDO1 | P14902 | 1/20 | 0.32 |
| ▸ | CYP11B2 | P19099 | 2/20 | 0.32 |
| ▸ | ESRRA | P11474 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL30865856 | 0.98 | POLB (0.36) | POLBRXRAGRIN1GRIN2BPARP1 | |
| Trifluoroacetic Acid SCHEMBL30141151 | 0.89 | GPR6 (0.33) | POLBRXRAGRIN1GRIN2BTHRB | |
| SCHEMBL30865862 | 0.79 | AR (0.46) | — | |
| Iodide SCHEMBL30865863 | 0.78 | AR (0.45) | — | |
| SCHEMBL29642574 | 0.69 | HCAR1 (0.42) | CYP11B2 | |
| SCHEMBL6284962 | 0.67 | MIF (0.35) | POLBRXRAGRIN1GRIN2BCYP11B2 | |
| SCHEMBL30141307 | 0.66 | IDO1 (0.44) | RXRAGRIN1GRIN2BIDO1 | |
| SCHEMBL21236133 | 0.63 | IDO1 (0.52) | IDO1 | |
| SCHEMBL15720883 | 0.62 | NOTUM (0.53) | RXRAGRIN1GRIN2B | |
| SCHEMBL17893817 | 0.62 | KMT2A (0.41) | RXRAGRIN1GRIN2BPARP1ABCC9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2911669-B1 | SYNERGISTIC COMBINATION OF IMMUNOLOGIC INHIBITORS FOR THE TREATMENT OF CANCER | UNIV CHICAGO (US) | 2024-04-10 | — | — | EP | disclosed |
| CN-107304191-B | Indolylamine 2,3-dioxygenase inhibitor and preparation method and application thereof | 上海翰森生物医药科技有限公司 | 2023-09-29 | — | — | CN | disclosed |
| CN-115745982-A | Oxadiazole compound and preparation method and application thereof | 中国药科大学 | 2023-03-07 | — | — | CN | disclosed |
| CN-111909107-B | IDO/HDAC dual inhibitor and pharmaceutical composition and application thereof | 药康众拓(江苏)医药科技有限公司 | 2023-02-03 | — | — | CN | disclosed |
| CN-107954999-B | Oxadiazole ring-containing compound, preparation method, intermediate, composition and application | 上海医药集团股份有限公司 | 2023-01-24 | — | — | CN | disclosed |
| CN-113105366-B | Phenyl-containing hydroximic structure derivatives, and preparation method and application thereof | 中国药科大学 | 2022-05-24 | — | — | CN | disclosed |
| CN-107033097-B | Oxadiazole derivative, preparation method and medical application thereof | 江苏恒瑞医药股份有限公司 | 2022-02-08 | — | — | CN | disclosed |
| CN-113105366-A | Phenyl-containing hydroximic structure derivatives, and preparation method and application thereof | 中国药科大学 | 2021-07-13 | — | — | CN | disclosed |
| EP-3389783-A1 | NOVEL COMPOUNDS AS INDOLEAMINE 2,3-DIOXYGENASE INHIBITORS | Merck Sharp & Dohme Corp. (US) | 2018-10-24 | — | — | EP | disclosed |
| WO-2017106062-A1 | NOVEL COMPOUNDS AS INDOLEAMINE 2,3-DIOXYGENASE INHIBITORS | MERCK SHARP & DOHME CORP. (US) | 2017-06-22 | — | — | WO | disclosed |